APVO · CIK 0001671584 · operating
Aptevo Therapeutics Inc. (APVO) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $11 million, Aptevo Therapeutics Inc. is a micro-cap company. The stock currently trades at $7.20, down 1.71% today, with a 52-week range of $5.94–$1440.00. The company trades at a trailing P/E of 0.0x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-87.38 | $-87.38 | -6053.5% | |
| 2023 | $-1.42 | $-1.42 | -190.4% | |
| 2022 | $1.57 | $1.57 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-02-14 | 0000950170-25-020467 | SEC ↗ |
| 2023-12-31 | 2024-03-05 | 0000950170-24-025428 | SEC ↗ |
| 2022-12-31 | 2023-03-30 | 0000950170-23-010757 | SEC ↗ |
| 2021-12-31 | 2022-03-24 | 0001564590-22-011575 | SEC ↗ |
| 2020-12-31 | 2021-03-31 | 0001564590-21-016875 | SEC ↗ |
| 2019-12-31 | 2020-03-25 | 0001564590-20-012791 | SEC ↗ |
| 2018-12-31 | 2019-03-18 | 0001564590-19-008184 | SEC ↗ |
| 2017-12-31 | 2018-03-13 | 0001564590-18-005384 | SEC ↗ |
| 2016-12-31 | 2017-03-31 | 0001564590-17-005738 | SEC ↗ |